iBio: Logos Global reports 0 shares owned
iBio, Inc. reporting persons led by Logos Global Management state they beneficially own 0 shares of Common Stock and report 0% ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
iBio, Inc. reporting persons led by Logos Global Management state they beneficially own 0 shares of Common Stock and report 0% ownership. The filing lists Logos Global, Logos Global GP, Logos Global Master Fund, Logos GP and Arsani William and disclaims group membership. The reporting persons certified the holdings and signed the amendment on 05/15/2026.
Insights
Schedules confirm no beneficial stake and no group affiliation.
The filing amends a Schedule 13G/A to state each reporting person has 0 shares and 0% ownership of iBio Common Stock. It expressly disclaims beneficial ownership under Rule 13d-3 and disclaims group status.
Cash‑flow treatment and any trading intentions are not included; subsequent filings would disclose any ownership changes. Signatures are dated 05/15/2026.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership regulatory
Rule 13d-3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Logos Global report for IBIO ownership?
Does the filing create a group under SEC rules for IBIO?
Who signed the Schedule 13G/A amendment for IBIO?
Does this filing indicate plans to acquire control of IBIO?
AI-generated analysis. How Rhea-AI works. Not financial advice.